For laboratory research use only — not for human consumption
For laboratory research use only — not for human consumption
Comparison
A neutral, structural comparison of GHK-Cu and MOTS-c as research compounds — written for researchers evaluating the two. It describes structure and research context only; it makes no human-use, dosing, or therapeutic claim. Both are supplied for in-vitro laboratory research use only.
| GHK-Cu | MOTS-c | |
|---|---|---|
| Class | Copper-binding tripeptide complex | Mitochondrial-derived peptide |
| Research area | Copper-peptide & matrix-signalling research | Mitochondrial-peptide research |
| CAS number | 49557-75-7 | 1627580-64-6 |
| Molecular formula | C14H22CuN6O4 | C101H152N28O22S2 |
| Sequence | Gly-His-Lys · Cu(II) | Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg |
| HPLC purity | 99.72% | 99% |
GHK-Cu is a naturally occurring copper-binding tripeptide complex (glycyl-L-histidyl-L-lysine bound to copper(II)) studied in laboratory research into matrix remodelling and copper-transport signalling. Its well-defined structure makes it a common reference compound in copper-peptide research.
MOTS-c is a mitochondrial-derived peptide (encoded within the mitochondrial genome) studied in laboratory research into mitochondrial and metabolic-signalling pathways. As one of the better-characterised mitochondrial-derived peptides, it is a frequent reference compound in this emerging research area.
Both compounds are supplied strictly for in-vitro laboratory research use only. Not for human or veterinary use. This comparison is structural and contextual and does not constitute advice on use.
